417 Shares in Intuitive Surgical, Inc. (NASDAQ:ISRG) Acquired by Galvin Gaustad & Stein LLC

Galvin Gaustad & Stein LLC acquired a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 417 shares of the medical equipment provider's stock, valued at approximately $218,000.

Several other institutional investors have also made changes to their positions in ISRG. Massachusetts Financial Services Co. MA acquired a new stake in shares of Intuitive Surgical in the 3rd quarter valued at $558,807,000. International Assets Investment Management LLC boosted its position in Intuitive Surgical by 49,383.6% in the third quarter. International Assets Investment Management LLC now owns 1,090,619 shares of the medical equipment provider's stock valued at $535,788,000 after buying an additional 1,088,415 shares in the last quarter. FMR LLC grew its stake in Intuitive Surgical by 8.3% during the third quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider's stock worth $5,389,765,000 after buying an additional 838,793 shares during the last quarter. Wilmington Savings Fund Society FSB increased its holdings in shares of Intuitive Surgical by 15,322.2% during the third quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider's stock worth $272,980,000 after buying an additional 552,058 shares in the last quarter. Finally, State Street Corp raised its stake in shares of Intuitive Surgical by 1.4% in the third quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider's stock valued at $7,393,673,000 after acquiring an additional 210,363 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical Stock Down 4.0 %

Intuitive Surgical stock traded down $24.61 during mid-day trading on Friday, hitting $584.05. 4,350,539 shares of the company's stock were exchanged, compared to its average volume of 1,997,346. The company's 50 day simple moving average is $546.03 and its 200-day simple moving average is $503.38. The firm has a market capitalization of $208.03 billion, a P/E ratio of 93.90, a PEG ratio of 5.19 and a beta of 1.39. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, EVP Robert Desantis sold 188 shares of the stock in a transaction dated Tuesday, October 29th. The stock was sold at an average price of $506.52, for a total transaction of $95,225.76. Following the completion of the transaction, the executive vice president now owns 5,506 shares in the company, valued at approximately $2,788,899.12. This represents a 3.30 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Jamie Samath sold 270 shares of the business's stock in a transaction dated Tuesday, December 10th. The shares were sold at an average price of $540.15, for a total value of $145,840.50. Following the completion of the sale, the chief financial officer now owns 8,757 shares in the company, valued at approximately $4,730,093.55. This trade represents a 2.99 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 42,475 shares of company stock valued at $22,070,807 over the last 90 days. 0.90% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on the company. Raymond James raised their price target on Intuitive Surgical from $560.00 to $688.00 and gave the company an "outperform" rating in a report on Friday. Evercore ISI reiterated a "cautious" rating on shares of Intuitive Surgical in a research report on Friday, October 18th. The Goldman Sachs Group set a $604.00 price objective on shares of Intuitive Surgical in a research report on Friday, October 18th. BTIG Research increased their price objective on Intuitive Surgical from $535.00 to $561.00 and gave the company a "buy" rating in a research report on Tuesday, November 26th. Finally, Robert W. Baird boosted their target price on Intuitive Surgical from $503.00 to $565.00 and gave the stock an "outperform" rating in a research report on Thursday, October 17th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have issued a buy rating to the company's stock. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $583.83.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.